DESITIN PHARMA A/S: Financial statements 2014
CVR: 19389006
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2014. In 2014, the company reported a gross profit of EUR 957,551 and a net result of EUR 287,303 compared with EUR 208,832 the year before. That is an increase of 8.7% compared with the year before. Equity in the 2014 report amounted to EUR 379,156. The solvency ratio was 72.1%.
- Gross Profit
- EUR 957,551
- Profit/Loss
- EUR 287,303
- Equity
- EUR 379,156
- Total Assets
- EUR 525,750
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 958 t. EUR | 287 t. EUR | 379 t. EUR | - |
| 2013 | - | 881 t. EUR | 209 t. EUR | 342 t. EUR | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,151,761 and a net result of DKK 288,733 compared with DKK 285,567 the year before. Equity in the 2025 report amounted to DKK 7,044,140.